Fulgent Genetics
FLGT
167 hedge funds and large institutions have $323M invested in Fulgent Genetics in 2025 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 59 increasing their positions, 51 reducing their positions, and 27 closing their positions.
1,300% more call options, than puts
Call options by funds: $8.89M | Put options by funds: $635K
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
17% more capital invested
Capital invested by funds: $276M → $323M (+$47.5M)
16% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 51
0.55% more ownership
Funds ownership: 52.86% → 53.41% (+0.55%)
5% less funds holding
Funds holding: 176 → 167 (-9)
26% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 27
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$9.92M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$6.08M |
| 3 |
Nuveen
Charlotte,
North Carolina
|
+$4.92M |
| 4 |
DC
Diametric Capital
Boston,
Massachusetts
|
+$3.29M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$3.27M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$10.3M |
| 2 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$7.57M |
| 3 |
JP Morgan Chase
New York
|
-$4.35M |
| 4 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
-$4M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$2.47M |
FLGT Hedge Fund Activity: Q2 2025 in Review
167 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q2 2025, worth a combined $323M — up 17% from $276M a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of FLGT and 20 opened new positions — a net loss of 7 holders — while 51 trimmed existing stakes and 59 added.
The largest buyer was Point72 Asset Management, adding an estimated $9.92M. The largest seller was Millennium Management, cutting an estimated $10.3M.
- 167 institutional investors held Fulgent Genetics (FLGT) as of Q2 2025, down from 176 in Q1 2025.
- Funds reported $323M of Fulgent Genetics stock for Q2 2025, up 17% quarter-over-quarter.
- 20 funds opened new Fulgent Genetics positions in Q2 2025 and 27 closed out, a net change of -7 holders.
- The largest Fulgent Genetics buyer in Q2 2025 was Point72 Asset Management, an estimated $9.92M added.
- The largest Fulgent Genetics seller in Q2 2025 was Millennium Management, an estimated $10.3M sold.
Based on aggregated 13F filings for Q2 2025.